Tian J.H., Zhang J.M., Hou Q.T., Oyang Q.H., Wang J.M., Luan Z.S., Chuan L., He
Y.J.
Multicentre trial on the efficacy and toxicity of single dose samarium 153 ethylene
diamine tetramethylene phosphonate as a palliative treatment for painful skeletal metas
tases in China. // Eur. J. Nucl. Med. — 1999. — V. 26(1). — P. 2 7.
Tong D., Gillick L., Hendrickson F.R.
The palliation of symptomatic osseus metas
tases // Cancer. — 1982. — V. 50. — P.893 894.
Tordiglione M., Luraghi R., Antognoni P.
Role of palliative and symptomatic radio
therapy in bone metastasis // Radiol. Med. (Torino). — 1999. — V. 97(5). — P. 372 337.
Tormey D.C., Weinberg V.E., Leone L.A., Glidewell O.J., Perloff M., Kennedy B.J.,
Cortes E., Silver R.T., Weiss R.B., Ainser J
. è ñîàâò. Comparison of intermittent as contin
uous and of adriamycin as methotrexate 5 drug chemotherapy for advanced breast cancer
// Amer. J. Clin. Oncol. — 1984 V. 7(3). — P. 231 239.
Traill Z., Richards M.A., Moore N.R.
Magnetic resonance imaging of metastatic
bone disease // Clin. Orthop. — 1995. — V. 312. — P. 76 88.
Tranum B., Hoogstraten B., Kennedy A., Vaughn C.B., Samal B., Thigpen T., Rivkin
S., Smith F., Palmer R.L., Constanzi J., Turcker W.J., Wikson H., Maloney T.R.
Adriamycin
in combination for the treatment of breast cancer // Cancer. — 1978. — V. 42. —
P. 2078 2083.
Travers M.T., Barrett+Lee P.J., Berger U.
Growth factor expression in normal,
benign and malignant breast tissue // Br. Med. J. — 1988. –V. 296. — P.1621 1624.
Treiberg R.
Hormon — und Chemotherapie des Mammakarzinoms // Therapiewoche.
— 1989. — V. 39(11). — P. 686 699.
Triedman S.A., Radie+Keane K.
The role of radiation therapy in the management of
bone metastases // Med. Health R. I. — 1996. — V. 79(4). — P. 135 138.
Trudeau M.E.
First line treatment of metastatic breast cancer // Anti Cancer
Drugs. — 1996. — V. 7(Suppl. 2). — P. 9 12.
Tryciecky E.W., Gottschalk A., Ludema K.
Oncologic imaging: interactions of
nuclear medicine with CT and MRI using the bone scan as a model // Semin. Nucl. Med. —
1997. — V. 27(2). — P. 142 151.
Tsuneto S., Kashivagi T.
Pain control in termunal cancer // Gan. To. Kagaku.
Ryoho. — 1989. — V. 16(4). — P. 759 766.
Tsuneto S., Hayashi A., Miyazaki M., Kashiwagi T.
A clinical survey of controlled
release morphine sulthate for cancer pain relief in a Japanese hospis // Postgrad. Med. J. —
1991. — V. 67. — P.79 81.
Tubiana+Hulin M., Turpin F., Goupil A., Floiras J.L., Delouche G.
Strategie de traite
ment des metastases osseuses des cancers mammaries // Sem. Hop. Paris. — 1984. — V.
42(60). — P. 2955 2962.
Tubiana+Hulin M.
Incidence, prevalence and distribution of bone metastases //
Bone. — 1991. — V. 12. — P. 9 10.
Tucker S.K., Dowd G.S.
Management of skeletal metastases // Br. J. Hosp. Med. —
1997. — V. 58(7). — P. 348 352.
Turkington R.
Prolactin receptors in mammary carcinoma cells // Cancer Res. —
1974. — V. 34. — P. 758 763.
Tyrrell C.J.
Role of pamidronate in the management of bone metastases from breast
cancer: results of a non comparative multicenter phase II trial. Aredia Multinational
Cooperative Group // Ann. Oncol. — 1994. — V. 5(Suppl. 7). — P. 37 40.
Twycross R.G., Fairfield S.
Pain in far advanced cancer // Pain. — 1982. — V. 14.
P. 303 310.
251
Êîñòíûå ìåòàñòàçû ðàêà ìîëî÷íîé æåëåçû
